Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh(AU:RMD)
A$35.44-0.97 (-2.66%)
AU:RMD
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh financials statements
A$35.44
At close:-0.97 (-2.66%)
Want to see AU:RMD full AI Analyst Report?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Ratios
210 Followers
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh Ratios
AU:RMD's free cash flow for Q1 2027 was $375.11M. For the 2027 fiscal year, AU:RMD's free cash flow was decreased by $-48.93M and operating cash flow was $424.03M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.10 | 3.44 | 2.59 | 3.12 | 2.80 |
| Quick Ratio | 2.42 | 2.53 | 1.69 | 1.81 | 1.72 |
| Cash Ratio | 1.05 | 1.19 | 0.26 | 0.30 | 0.40 |
| Solvency Ratio | 0.76 | 0.74 | 0.62 | 0.42 | 0.56 |
| Operating Cash Flow Ratio | 1.32 | 1.72 | 1.54 | 0.91 | 0.51 |
| Short-Term Operating Cash Flow Coverage | 7.10 | 176.93 | 39.83 | 21.79 | 11.05 |
| Net Current Asset Value | $ 1.94B | $ 1.30B | $ 349.37M | $ -253.97M | $ 196.38M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.09 | 0.10 | 0.13 | 0.23 | 0.18 |
| Debt-to-Equity Ratio | 0.13 | 0.14 | 0.18 | 0.38 | 0.27 |
| Debt-to-Capital Ratio | 0.11 | 0.12 | 0.16 | 0.28 | 0.21 |
| Long-Term Debt-to-Capital Ratio | 0.06 | 0.10 | 0.13 | 0.26 | 0.19 |
| Financial Leverage Ratio | 1.36 | 1.37 | 1.41 | 1.63 | 1.52 |
| Debt Service Coverage Ratio | 6.93 | 56.06 | 15.94 | 14.58 | 18.41 |
| Interest Coverage Ratio | 0.00 | 86.56 | 28.88 | 23.89 | 44.83 |
| Debt to Market Cap | 0.02 | 0.02 | 0.03 | 0.05 | 0.03 |
| Interest Debt Per Share | 0.57 | 0.59 | 0.64 | 1.11 | 0.64 |
| Net Debt to EBITDA | -0.29 | -0.19 | 0.43 | 1.00 | 0.55 |
| Profitability Margins | |||||
| Gross Profit Margin | 60.25% | 59.36% | 56.67% | 55.78% | 56.57% |
| EBIT Margin | 33.96% | 32.79% | 27.97% | 27.52% | 27.47% |
| EBITDA Margin | 38.19% | 37.37% | 32.73% | 32.18% | 32.88% |
| Operating Profit Margin | 33.96% | 32.75% | 28.17% | 26.80% | 27.96% |
| Pretax Profit Margin | 33.95% | 32.60% | 27.00% | 26.09% | 26.84% |
| Net Profit Margin | 26.94% | 27.22% | 21.79% | 21.25% | 21.78% |
| Continuous Operations Profit Margin | 26.94% | 27.22% | 21.79% | 21.25% | 21.78% |
| Net Income Per EBT | 79.36% | 83.50% | 80.72% | 81.47% | 81.15% |
| EBT Per EBIT | 99.97% | 99.54% | 95.83% | 97.33% | 96.02% |
| Return on Assets (ROA) | 17.37% | 17.14% | 14.86% | 13.29% | 15.30% |
| Return on Equity (ROE) | 23.65% | 23.47% | 20.99% | 21.73% | 23.19% |
| Return on Capital Employed (ROCE) | 25.93% | 23.55% | 22.14% | 18.89% | 22.70% |
| Return on Invested Capital (ROIC) | 19.82% | 19.56% | 17.69% | 15.25% | 18.20% |
| Return on Tangible Assets | 27.79% | 30.04% | 28.80% | 26.17% | 27.70% |
| Earnings Yield | 5.35% | 3.69% | 3.65% | 2.80% | 2.52% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.58 | 5.19 | 5.60 | 5.99 | 6.21 |
| Payables Turnover | 7.44 | 7.52 | 8.54 | 12.39 | 9.76 |
| Inventory Turnover | 2.43 | 2.25 | 2.47 | 1.87 | 2.09 |
| Fixed Asset Turnover | 7.86 | 7.16 | 6.70 | 6.34 | 5.68 |
| Asset Turnover | 0.64 | 0.63 | 0.68 | 0.63 | 0.70 |
| Working Capital Turnover Ratio | 2.13 | 2.62 | 3.07 | 2.96 | 3.76 |
| Cash Conversion Cycle | 166.62 | 183.63 | 170.33 | 226.54 | 196.09 |
| Days of Sales Outstanding | 65.44 | 70.26 | 65.23 | 60.93 | 58.75 |
| Days of Inventory Outstanding | 150.26 | 161.91 | 147.84 | 195.08 | 174.75 |
| Days of Payables Outstanding | 49.08 | 48.55 | 42.74 | 29.47 | 37.41 |
| Operating Cycle | 215.69 | 232.17 | 213.07 | 256.00 | 233.50 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.27 | 1.19 | 0.95 | 0.47 | 0.24 |
| Free Cash Flow Per Share | 1.16 | 1.13 | 0.87 | 0.38 | 0.13 |
| Dividend Paid and CapEx Coverage Ratio | 3.57 | 4.26 | 3.53 | 1.77 | 0.87 |
| Capital Expenditure Coverage Ratio | 11.55 | 17.40 | 12.20 | 5.17 | 2.25 |
| Operating Cash Flow Coverage Ratio | 2.24 | 2.06 | 1.56 | 0.44 | 0.38 |
| Operating Cash Flow to Sales Ratio | 0.32 | 0.34 | 0.30 | 0.16 | 0.10 |
| Free Cash Flow Yield | 5.80% | 4.35% | 4.59% | 1.75% | 0.63% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 18.67 | 26.89 | 27.43 | 35.70 | 39.69 |
| Price-to-Sales (P/S) Ratio | 5.03 | 7.38 | 5.98 | 7.59 | 8.65 |
| Price-to-Book (P/B) Ratio | 4.42 | 6.36 | 5.76 | 7.76 | 9.21 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 17.25 | 23.01 | 21.77 | 57.30 | 158.56 |
| Price-to-Operating Cash Flow Ratio | 15.76 | 21.68 | 19.98 | 46.22 | 88.10 |
| Price-to-Earnings Growth (PEG) Ratio | 1.68 | 0.74 | 1.61 | 1.85 | 0.74 |
| Enterprise Value Multiple | 12.89 | 19.56 | 18.69 | 24.58 | 26.84 |
| Enterprise Value | 28.43B | 37.63B | 28.66B | 33.40B | 31.58B |
| EV to EBITDA | 12.89 | 19.56 | 18.69 | 24.58 | 26.84 |
| EV to Sales | 4.92 | 7.31 | 6.12 | 7.91 | 8.83 |
| EV to Free Cash Flow | 16.87 | 22.79 | 22.28 | 59.71 | 161.86 |
| EV to Operating Cash Flow | 15.41 | 21.48 | 20.46 | 48.17 | 89.94 |
| Tangible Book Value Per Share | 2.21 | 1.67 | 1.04 | 0.55 | 0.74 |
| Shareholders’ Equity Per Share | 4.52 | 4.07 | 3.31 | 2.81 | 2.30 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.21 | 0.17 | 0.19 | 0.19 | 0.19 |
| Revenue Per Share | 3.97 | 3.51 | 3.19 | 2.88 | 2.45 |
| Net Income Per Share | 1.07 | 0.95 | 0.69 | 0.61 | 0.53 |
| Tax Burden | 0.79 | 0.83 | 0.81 | 0.81 | 0.81 |
| Interest Burden | 1.00 | 0.99 | 0.97 | 0.95 | 0.98 |
| Research & Development to Revenue | 0.07 | 0.06 | 0.07 | 0.07 | 0.07 |
| SG&A to Revenue | 0.20 | 0.19 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.02 | 0.02 | 0.02 | 0.02 |
| Income Quality | 1.19 | 1.25 | 1.37 | 0.77 | 0.45 |
Currency in USD

